Familial Pancreatic Cancer PROPHilation Program in Italy — PROPH-ITA  

Candidates for Hereditary Pancreatic Cancer Testing Clinical Trial

Official title: Standardised Genetic Profiling of Subjects Belonging to the Italian Multicenter Registry of Prospective Surveillance of Subjects at Genetic Risk of Pancreatic Cancer

Status Recruiting

Clinical Trial Summary

The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only.

Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test.

Up to 3,000 participants will be enrolled in this study.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Candidates for Hereditary Pancreatic Cancer Testing
• Pancreatic Neoplasms

• NCT number: NCT05724992
• Study type: Interventional
• Source: Associazione Italiana per lo Studio del Pancreas
• Contact: Erica Secchettin, PharmD
• Phone: 0458126254
• Email: familiarita.aisp@gmail.com
• Status: Recruiting
• Phase: N/A
• Start date: December 20, 2022
• Completion date: December 20, 2028